Product Images Revatio

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 28 images provide visual information about the product associated with Revatio NDC 0069-0336 by Pfizer Laboratories Div Pfizer Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 - revatio 01

Figure 1 - revatio 01

Figure 2 - revatio 02

Figure 2 - revatio 02

Figure 3 - revatio 03

Figure 3 - revatio 03

Figure 4 - revatio 04

Figure 4 - revatio 04

Figure 5 - revatio 05

Figure 5 - revatio 05

Figure 6 - revatio 06

Figure 6 - revatio 06

Chemical Structure - revatio 07

Chemical Structure - revatio 07

Figure 7 - revatio 08

Figure 7 - revatio 08

This is a table of drug interactions with Sildenafil, where recommendations for doses adjustments are given based on the fold change and 90% confidence interval. Atorvastatin, Azithromycin, Cimetidine, Erythromycin, and Oral Contraceptives do not require dose adjustments concerning Auc and Cmax. On the other hand, Bosentan and Saquinavir do not need dose adjustment for Cmax but do have it for Auc. Finally, Ritonavir has an Auc fold change of H84, and a dose adjustment is not recommended. A note points out that the combination of bosentan and sildenafil does not improve exercise capacity.*

Figure 8 - revatio 09

Figure 8 - revatio 09

This appears to be a list of drugs that interact with 'Acenocoumarol'. Each interaction has information on the effect on 'INR AUC', 'INR Cmax', 'BT', 'AuC', and 'Cmax'. There is also a recommendation for each interaction, which includes no dose adjustment or not recommended. One note mentions the lack of improvement in exercise capacity when sildenafil is added to bosentan therapy.*

Figure 9 - revatio 10

Figure 9 - revatio 10

This appears to be a table showing the change from baseline (measured in meters) for each week of a study where participants were given different doses of a drug called sildenafil. The key indicates the different dosages given: 40mg TID, 80mg TID, 20mg TID, or a placebo. There is not enough information to determine the context or purpose of the study.*

Figure 10 - revatio 11

Figure 10 - revatio 11

Figure 11 - revatio 12

Figure 11 - revatio 12

Figure 12 - revatio 13

Figure 12 - revatio 13

The plot displays the average change from the baseline with the corresponding standard error for each treatment at every visit up to week 12. There are also numerical values represented on the graph, showing the change from the baseline in meters. Additionally, there is information about the different dosages of Sildenafil given three times a day - 6mg, 9mg, and 20mg.*

Logo - revatio 14

Logo - revatio 14

This text is a description of the distributor of a product which is Pfizer Labs. It is a division of Pfizer Inc, located in NY, NY 10017.*

revatio 14a

revatio 14a

This is a description of a company called Pfizer Labs, which is a division of Pfizer Inc. located in NY, NY 10017. They distribute products, but the specific type of products is not mentioned.*

Figure A - revatio 15

Figure A - revatio 15

The text describes a "syringe adaptor" along with a "bottle of REVATIO oral suspension". It also mentions a "barrel" and a "plunger". However, without additional context or information, it is unclear how these components are related or what purpose they serve.*

Figure B - revatio 16

Figure B - revatio 16

Figure C - revatio 17

Figure C - revatio 17

Figure D - revatio 18

Figure D - revatio 18

Figure E - revatio 19

Figure E - revatio 19

Figure F - revatio 20

Figure F - revatio 20

Figure G - revatio 21

Figure G - revatio 21

revatio 21a

revatio 21a

This text is a notation indicating that Pfizer Labs is the distributor of a product or products that come from a division of the Pfizer Inc. company located in New York, with zip code 10017.*

PRINCIPAL DISPLAY PANEL - 20 mg Bottle Label - revatio 22

PRINCIPAL DISPLAY PANEL - 20 mg Bottle Label - revatio 22

This is a prescription drug called Revatio (sildenafil) which is distributed by Pfizer Labs. The drug comes in the form of tablets and is stored at a controlled room temperature between 68°F to 77°F with permissible temperature excursions ranging from 59°F to 86°F. The drug should only be dispensed in light containers as per USP. The dosage and use instructions can be found in the accompanying prescribing information. However, some of the text is unreliable due to errors.*

PRINCIPAL DISPLAY PANEL - 10 mg/12.5 mL Vial Label - revatio 23

PRINCIPAL DISPLAY PANEL - 10 mg/12.5 mL Vial Label - revatio 23

Store the medication at a controlled room temperature between 68°F to 77°F. Excursions permitted to 59°F to 86°F. It is a sterile single-use injection containing 1.126 mg of sildenafil, 50.5 mg of dextrose, and 10 mg of water for injection. The medication is for intravenous use only. There are accompanying instructions for usage.*

PRINCIPAL DISPLAY PANEL - 10 mg/12.5 mL Vial Carton - revatio 24

PRINCIPAL DISPLAY PANEL - 10 mg/12.5 mL Vial Carton - revatio 24

This is a description of a medicine called "Revatio®". It is a sterile single-use injection containing 10 mg/12.5 mL (0.8 mg/ml) of sildenafil for intravenous use. The solution also contains dextrose and water for injection. The dosage and use instructions are mentioned in the accompanying prescribing information. The injection needs to be discarded if unused. The medicine is packaged in a vial with a unique product identifier (GTIN: 0300690338019) and distributed by Pfizer Labs. It needs to be stored at controlled room temperature (20°C - 25°C) with permitted excursions to 15°C - 30°C (see USP controlled room temperature). The product is manufactured in Ireland.*

PRINCIPAL DISPLAY PANEL - 10 mg/mL Bottle Label - revatio 25

PRINCIPAL DISPLAY PANEL - 10 mg/mL Bottle Label - revatio 25

This text provides instructions for storing and using a medication called Revatio (containing sildenafil) before and after reconstitution. The medication should be stored below 30°C before reconstitution, and after reconstitution, it can be stored in a refrigerator. The medication should not be frozen and any unused portion should be discarded after 60 days. Each mL of the suspension contains 10 mg of sildenafil, and the recommended dosage should be followed as per the prescribing information. The medication is meant for oral use only and is grape-flavored. The details of lot and expiration date are not available.*

PRINCIPAL DISPLAY PANEL - 10 mg/mL Bottle Carton - revatio 26

PRINCIPAL DISPLAY PANEL - 10 mg/mL Bottle Carton - revatio 26

Revatio® is a sildenafil-based oral suspension, available in a grape flavor. It is meant to be used for oral purposes only, after being shaken well. The suspension needs to be reconstituted first, as directed in the packaging. The recommended dosage can be found in the prescribing information. The reconstituted suspension needs to be stored below 30°C or in refrigeration below 2°-8°, and not refrigerated again or used after 60 days. The package contains a dosing syringe and a press-and-release bottle adapter. The product is distributed by Pfizer Labs and made in Finland.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.